JWJo Weeks

Jo Weeks

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jo Weeks has a total of 2 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Trustworthiness assessment of published clinical trials: Literature review of domains and questions

    by Zarko Alfirevic, Jo Weeks

    Background: Historically, peer reviewing has focused on the importance of research questions/hypotheses, appropriateness of research methods, risk of bias, and quality of writing. Until recently, the issues related to trustworthiness—including but not limited to plagiarism and fraud—have been largely neglected because of lack of awareness and lack of adequate tools/training. We set out to identify all relevant papers that have tackled the issue of trustworthiness assessment to identify key domains that have been suggested as an integral part of any such assessment.Methods: We searched the literature for publications of tools, checklists, or methods used or proposed for the assessment of trustworthiness of randomized trials. Data items (questions) were extracted from the included publications and transcribed on Excel including the assessment domain. Both authors then independently recategorised each data item in five domains (governance, plausibility, plagiarism, reporting, and statistics).Results: From the 41 publications we extracted a total of 284 questions and framed 77 summary questions grouped in five domains: governance (13 questions), plausibility (17 questions), plagiarism (4 questions), reporting (29 questions), and statistics (14 questions).Conclusion: The proposed menu of domains and questions should encourage peer reviewers, editors, systematic reviewers and developers of guidelines to engage in a more formal trustworthiness assessment. Methodologists should aim to identify the domains and questions that should be considered mandatory, those that are optional depending on the resources available, and those that could be discarded because of lack of discriminatory power.


  • Open Access

    Trustworthiness assessment as an inclusion criterion for systematic reviews—What is the impact on results?

    by Jo Weeks, Anna Cuthbert, Zarko Alfirevic

    Background: There is increasing concern that a significant proportion of randomized controlled trials (RCTs) included in Cochrane reviews may not be trustworthy. Applying the Cochrane Pregnancy and Childbirth Trustworthiness Screening Tool (CPC‐TST) has already had a clinically important effect on several reviews published by the Cochrane Pregnancy and Childbirth Group. Objectives: We wanted to assess the impact of removing untrustworthy RCTs from already‐published Cochrane reviews on a defined clinical area (antenatal and postnatal nutritional interventions). Methods: We applied the tool to 18 Cochrane reviews (374 RCTs). The tool had four domains: (i) is the research governance trustworthy; (ii) are the baseline characteristics trustworthy; (iii) is the study feasible; (iv) are the results plausible? When additional information was needed, authors were contacted using a standard template. At least two attempts were made to contact the authors. At the end of the evaluation process each study was classified as: (i) included (YES to all questions); (ii) excluded (retracted study); or (iii) awaiting classification (any NO to the questions). Results: Ninety‐three out of 374 included studies (25%) were reclassified as “excluded” or “awaiting classification.” The number of included RCTs was reduced in 14 out of 18 reviews. Six reviews (33%) were judged to require updating because of important differences in the Summary of Findings tables (direction and size of effects and/or GRADE ratings), conclusions, implication for practice, and/or implication for research. Conclusions: Formal assessment of trustworthiness, and inclusion only of studies that satisfy prespecified criteria for trustworthiness, affect conclusions in a relatively large number of Cochrane reviews, with potentially important clinical implications for practice and research.